Hans K Ghayee

6PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsMolecular targetsCancer geneticsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 06, 2026
Targeted lipidomics between hPheo1 and SDHB KD cells reveal changes in bioactive lipids and PKC with polyamine pathway inhibition.

|Feb 21, 2024
Niche for polyamine inhibition in treatment of metastatic pheochromocytoma and paraganglioma.

Hans K Ghayee, Heather Hatch, Raymond J Bergeron

|Feb 10, 2023
Metabolic Characterization and Glyceraldehyde-3-Phosphate Dehydrogenase-Dependent Regulation of Epithelial Sodium Channels in hPheo1 Wild-type and SDHB Knockdown Cells.

Niharika Bala, Ling Yu, Lauren P Liu

|Aug 20, 2021
Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma.

Katerina Hadrava Vanova, Ying Pang, Linda Krobova

|Jul 22, 2020
Phosphoprotein-based biomarkers as predictors for cancer therapy.

Angela M Carter, Chunfeng Tan, Karine Pozo

|Dec 30, 2019
Molecular Mechanisms of Primary Aldosteronism.

Sergei G Tevosian, Shawna C Fox, Hans K Ghayee

Pageof 1

Frequent Collaborators

2 joint publications

Karel Pacak

2 joint publications

Abdel A Alli

1 joint publications

Sergei G Tevosian

1 joint publications

Chunfeng Tan